Fresh, sourced stories worth posting about for venture capitalists — updated every few hours, with the receipts attached. Not generated guesses.
Your desk is ready
Free to start · no card required · your pick is waiting on the other side.
Niche's weekly rollup — one email, no spam.
The stories refresh every few hours from live news and primary sources. Each carries the publisher and the date it was published — so you can see exactly how current it is.
Real reporting and primary filings — every story links its sources. Nothing here is a generated guess; the angle is identified and the receipts are attached.
Yes. These are starting points for your own posts. Draft one and Niche writes it in your voice, platform-native, ready to publish.
A set of company-level signals spanning clinical-stage assets and public market disclosures, including Neuphoria Therapeutics' 8-K, Paymentus and Accel insider activity, and the broader IPO pipeline list. For venture investors, this reflects capital-markets context around exits, financing, and company milestones.
Draft a post from this →Late-stage and recruiting studies in psoriasis, hidradenitis suppurativa, hypertension, and acne mRNA vaccination show continued clinical momentum in dermatology and immune-mediated disease. The acne vaccine program stands out as a notable platform-style bet.
Draft a post from this →A cluster of late-stage and recruiting clinical trials across psychiatry, neurology, pain, and related behavioral health areas, including PTSD, OCD, Alzheimer's screening, cannabis withdrawal, and chronic low back pain. This reflects ongoing venture-relevant pipeline movement in therapeutics and neuromodulation-adjacent innovation.
Draft a post from this →Trials using smartphones, video feedback, and mHealth approaches to improve physical activity, gait analysis, rehabilitation, and physical function across diabetes, cerebral palsy, orthopedic recovery, and aging populations. The thread points to continued experimentation in digital health and remote monitoring tools.
Draft a post from this →NIH funding awards and research-velocity metadata point to ongoing investment in translational infrastructure, shared resources, and entrepreneurship-adjacent training. This is a softer but relevant signal for the innovation funnel feeding future startups and venture opportunities.
Draft a post from this →